The role of the neuropeptide y2 receptor in liporemodeling: Neuropeptide y-mediated adipogenesis and adipose graft maintenance

Plastic and Reconstructive Surgery

Volumn 123, Issue 2, 2009, Pages 486-492

  Baker, Stephen B ^a,b   Cohen, Michael ^a,b   Kuo, Lydia ^a,b   Johnson, Michael ^a,b   Al Attar, Ali ^a,b   Zukowska, Zofia ^a,b  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR AGONIST; PLACEBO; UNCLASSIFIED DRUG; NEUROPEPTIDE Y RECEPTOR;

ADIPOGENESIS; ADIPOSE TISSUE; ADIPOSE TISSUE CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; EXPERIMENTAL MODEL; GRAFT SURVIVAL; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MONKEY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; PLASTIC SURGERY; PRIMATE; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE; TISSUE GROWTH; VASCULARIZATION; XENOGRAFT; ABDOMINAL FAT; ADIPOCYTE; ANIMAL; C57BL MOUSE; CYTOLOGY; FEMALE; GROWTH, DEVELOPMENT AND AGING; MACACA; METABOLISM; METHODOLOGY; NUDE MOUSE; PHYSIOLOGY; TRANSPLANTATION;

ABDOMINAL FAT; ADIPOCYTES; ADIPOGENESIS; ANIMALS; FEMALE; GRAFT SURVIVAL; HUMANS; MACACA MULATTA; MALE; MICE; MICE, INBRED C57BL; MICE, NUDE; NEUROPEPTIDE Y; RECEPTORS, NEUROPEPTIDE Y; TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 61449250849     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181954c80     Document Type: Article

References (12)

1. Kuo LE, Kitlinska JB, Tilan JU, et al. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med. 2007;13: 803.
2. Larhammar D. Evolution of neuropeptide Y, peptide YY, and pancreatic polypeptide. Regul Pept. 1996;62:1.
3. Zukowska-Grojec Z, Karwatowska-Prokopczukk E, Rose W, et al. Neuropeptide Y: A novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res. 1998;83:187.
4. Coleman SR. My view: Structural fat grafting. Aesthetic Surg J. 1998;18:386.
5. Coleman SR. Structural fat grafts: The ideal filler? Clin Plast Surg. 2001;28:11.
6. Spear SL, Wilson HB, Lockwood MD. Fat injection to correct contour deformities in the reconstructed breast. Plast Reconstr Surg. 2005;116:1300.
7. Coleman SR, Saboeiro AP. Fat grafting to the breast revisited: Safety and efficacy. Plast Reconstr Surg. 2007;119:775.
8. Murillo WL. Buttock augmentation: Case studies of fat injection monitored by magnetic resonance imaging. Plast Reconstr Surg. 2004;114:1606.
9. Rubin JP, Bennett JM, Doctor JS, Tebbets BM, Mara KG. Collagenous microbeads as a scaffold for tissue engineering with adipose-derived stem cells. Plast Reconstr Surg. 2007;120: 414.
10. Nastech reports positive PYY nasal spray clinical trial data and will advance obesity clinical program in 2007. Available at: http://www. medicalnewstoday.com/articles/59640.php. Accessed July 30, 2007.
11. BrandtG, ParkA,WynneK,etal. Nasal peptide YY3-36: Phase 1 dose ranging & safety studies in healthy human subjects. Presented at the 86th Annual Meeting of the Endocrine Society, New Orleans, La., June 16-19, 2004.
12. Park A, Wynne K, Sileno A, et al. Nasal peptide YY 3-36: Phase 1 dose ranging and safety study in healthy human subjects. Presented at the 13th European Congress on Obesity, Prague, Czech Republic, May 26-29, 2004.